These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10668412)

  • 21. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.
    Wright DW; Kellermann AL; Hertzberg VS; Clark PL; Frankel M; Goldstein FC; Salomone JP; Dent LL; Harris OA; Ander DS; Lowery DW; Patel MM; Denson DD; Gordon AB; Wald MM; Gupta S; Hoffman SW; Stein DG
    Ann Emerg Med; 2007 Apr; 49(4):391-402, 402.e1-2. PubMed ID: 17011666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.
    Plenger PM; Dixon CE; Castillo RM; Frankowski RF; Yablon SA; Levin HS
    Arch Phys Med Rehabil; 1996 Jun; 77(6):536-40. PubMed ID: 8831468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group.
    Albers GW; Atkinson RP; Kelley RE; Rosenbaum DM
    Stroke; 1995 Feb; 26(2):254-8. PubMed ID: 7831698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the monoaminergic stabiliser (-)-OSU6162 on mental fatigue following stroke or traumatic brain injury.
    Nilsson MKL; Johansson B; Carlsson ML; Schuit RC; Rönnbäck L
    Acta Neuropsychiatr; 2020 Dec; 32(6):303-312. PubMed ID: 32418546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase Ib Randomized Controlled Study to Evaluate the Effectiveness of a Single-Dose of the NR2B Selective N-Methyl-D-Aspartate Antagonist MK-0657 on Levodopa-Induced Dyskinesias and Motor Symptoms in Patients With Parkinson Disease.
    Herring WJ; Assaid C; Budd K; Vargo R; Mazenko RS; Lines C; Ellenbogen A; Verhagen Metman L
    Clin Neuropharmacol; 2017; 40(6):255-260. PubMed ID: 29059133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke.
    Dyker AG; Edwards KR; Fayad PB; Hormes JT; Lees KR
    Stroke; 1999 Oct; 30(10):2038-42. PubMed ID: 10512904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.
    Firsching R; Piek J; Skalej M; Rohde V; Schmidt U; Striggow F;
    J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):204-16. PubMed ID: 22696266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.
    Mazzeo AT; Brophy GM; Gilman CB; Alves OL; Robles JR; Hayes RL; Povlishock JT; Bullock MR
    J Neurotrauma; 2009 Dec; 26(12):2195-206. PubMed ID: 19621985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen.
    Kaste M; Murayama S; Ford GA; Dippel DW; Walters MR; Tatlisumak T;
    Cerebrovasc Dis; 2013; 36(3):196-204. PubMed ID: 24135530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selfotel in acute ischemic stroke : possible neurotoxic effects of an NMDA antagonist.
    Davis SM; Lees KR; Albers GW; Diener HC; Markabi S; Karlsson G; Norris J
    Stroke; 2000 Feb; 31(2):347-54. PubMed ID: 10657404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
    Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
    Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A clinical trial of progesterone for severe traumatic brain injury.
    Skolnick BE; Maas AI; Narayan RK; van der Hoop RG; MacAllister T; Ward JD; Nelson NR; Stocchetti N;
    N Engl J Med; 2014 Dec; 371(26):2467-76. PubMed ID: 25493978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial.
    Temkin NR; Anderson GD; Winn HR; Ellenbogen RG; Britz GW; Schuster J; Lucas T; Newell DW; Mansfield PN; Machamer JE; Barber J; Dikmen SS
    Lancet Neurol; 2007 Jan; 6(1):29-38. PubMed ID: 17166799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.